{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:08:29Z","timestamp":1791162509321,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T00:00:00Z","timestamp":1322611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11307-011-0527-x","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T21:10:05Z","timestamp":1322687405000},"page":"637-646","source":"Crossref","is-referenced-by-count":46,"title":["99mTc-labeled Rituximab for Imaging B Lymphocyte Infiltration in Inflammatory Autoimmune Disease Patients"],"prefix":"10.1007","volume":"14","author":[{"given":"G.","family":"Malviya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. L.","family":"Anzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Podest\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Scopinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Signore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,30]]},"reference":[{"issue":"7","key":"527_CR1","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1182\/blood-2005-07-2891","volume":"106","author":"F Hiepe","year":"2005","unstructured":"Hiepe F, Radbruch A (2005) B cells in autoimmunity: more than antibodies? Blood 106(7):2227","journal-title":"Blood"},{"key":"527_CR2","doi-asserted-by":"publisher","first-page":"8750","DOI":"10.1073\/pnas.97.16.8750","volume":"97","author":"NA Mitchison","year":"2000","unstructured":"Mitchison NA, Wedderburn LR (2000) B cells in autoimmunity. Proc Natl Acad Sci USA 97:8750\u20138751","journal-title":"Proc Natl Acad Sci USA"},{"key":"527_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2165\/00063030-200115020-00001","volume":"15","author":"A Gause","year":"2001","unstructured":"Gause A, Berek C (2001) The role of B cells in the pathogenesis of rheumatoid arthritis. Potential implications for treatment. BioDrugs 15:73\u201379","journal-title":"BioDrugs"},{"key":"527_CR4","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.167.8.4710","volume":"167","author":"S Takemura","year":"2001","unstructured":"Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM (2001) T cell activation in rheumatoid synovium is B cell dependent. J Immunol 167:4710\u20134718","journal-title":"J Immunol"},{"key":"527_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0889-857X(05)70205-2","volume":"27","author":"Z Zhang","year":"2001","unstructured":"Zhang Z, Bridges SL (2001) Pathogenesis of rheumatoid arthritis. Role of B-lymphocytes. Rheum Dis Clin North Am 27:335\u2013353","journal-title":"Rheum Dis Clin North Am"},{"key":"527_CR6","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00002281-200305000-00011","volume":"15","author":"T D\u00f6rner","year":"2003","unstructured":"D\u00f6rner T, Burmester GR (2003) The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr Opin Rheumatol 15:246\u2013252","journal-title":"Curr Opin Rheumatol"},{"key":"527_CR7","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.125.4.1678","volume":"125","author":"P Stashenko","year":"1980","unstructured":"Stashenko P, Nadler LM, Hardy R, Schlossman SF (1980) Characterization of a human B-lymphocyte-specific antigen. J Immunol 125:1678\u20131685","journal-title":"J Immunol"},{"issue":"2","key":"527_CR8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4049\/jimmunol.135.2.973","volume":"135","author":"TF Tedder","year":"1985","unstructured":"Tedder TF, Boyd AW, Freedman AS, Nadler LM, Schlossman SF (1985) The B cell surface molecule B1 is functionally linked with B-cell activation and differentiation. J Immunol 135(2):973\u2013979","journal-title":"J Immunol"},{"key":"527_CR9","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1002\/art.22967","volume":"56","author":"YK Teng","year":"2007","unstructured":"Teng YK, Levarht EW, Hashemi M, Bajema IM, Toes RE, Huizinga TW, van Laar JM (2007) Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. Arthritis Rheum 56:3909\u20133918","journal-title":"Arthritis Rheum"},{"issue":"8","key":"527_CR10","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/art.10467","volume":"46","author":"S Vita De","year":"2002","unstructured":"De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G (2002) Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis, evidence for a pathogenetic role of B cells. Arthritis Rheum 46(8):2029\u20132033","journal-title":"Arthritis Rheum"},{"issue":"6","key":"527_CR11","first-page":"654","volume":"54","author":"G Malviya","year":"2010","unstructured":"Malviya G, Galli F, Sonni I, Pacilio M, Signore A (2010) Targeting T and B lymphocytes with radiolabelled antibodies for diagnostic and therapeutic applications. Q J Nucl Med Mol Imaging 54(6):654\u2013676","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"527_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.pharmthera.2010.01.001","volume":"125","author":"T D\u00f6rner","year":"2010","unstructured":"D\u00f6rner T, Kinnman N, Tak PP (2010) Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers. Pharmacol Ther 125:464\u2013475","journal-title":"Pharmacol Ther"},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.clinthera.2008.10.017","volume":"30","author":"DJ Burge","year":"2008","unstructured":"Burge DJ, Bookbinder SA, Kivitz A, Fleischmann RM, Shu C, Bannink J (2008) Pharmacokinetic and pharmacodynamic properties of TRU-015, a CE20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a phase I, open-label, dose-escalation clinical study. Clin Ther 30:1806\u20131816","journal-title":"Clin Ther"},{"issue":"suppl 10","key":"527_CR14","first-page":"S148","volume":"60","author":"S Stromatt","year":"2009","unstructured":"Stromatt S, Chopiak V, Dvoretskiy L et al (2009) Sustained safety and efficacy of TRU-015 with continued retreatment of rheumatoid arthritis subjects following a phase 2B study [abstract 403]. Arthritis Rheum 60(suppl 10):S148\u2013S149","journal-title":"Arthritis Rheum"},{"issue":"2","key":"527_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s00259-009-1272-0","volume":"37","author":"G Malviya","year":"2010","unstructured":"Malviya G, Conti F, Chianelli M, Scopinaro F, Dierckx RA, Signore A (2010) Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies. Eur J Nucl Med Mol Imaging 37(2):386\u2013398","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"527_CR16","first-page":"1","volume":"51","author":"C D\u2019Alessandria","year":"2007","unstructured":"D\u2019Alessandria C, Malviya G, Viscido A, Aratari A, Maccioni F, Amato A, Scopinaro F, Caprilli R, Signore A (2007) Use of a 99\u00a0m-technetium labelled anti-TNF-\u03b1 monoclonal antibody in Crohn\u2019s Disease: in vitro and in vivo studies. Q J Nucl Med Mol Imaging 51:1\u20139","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"527_CR17","first-page":"1784","volume":"45","author":"AO Schaffland","year":"2004","unstructured":"Schaffland AO, Buchegger F, Kosinski M, Antonescu C, Paschoud C, Grannavel C, Pellikka R, Delaloye AB (2004) 131I-rituximab: relationship between immunoreactivity and specific activity. J Nucl Med 45:1784\u20131790","journal-title":"J Nucl Med"},{"key":"527_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0022-1759(84)90435-6","volume":"72","author":"T Lindmo","year":"1984","unstructured":"Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr (1984) Determination of the immunoreactive fraction of radiolabelled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 72:77\u201389","journal-title":"J Immunol Methods"},{"key":"527_CR19","first-page":"S93","volume":"23","author":"J Fransen","year":"2005","unstructured":"Fransen J, van Riel PLCM (2005) The disease activity score and the EULAR response criteria. Clin Exp Rheumatol 23:S93\u2013S99","journal-title":"Clin Exp Rheumatol"},{"key":"527_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630\u2013640","journal-title":"Arthritis Rheum"},{"issue":"3","key":"527_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"key":"527_CR22","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665\u20132673","journal-title":"Arthritis Rheum"},{"key":"527_CR23","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC (1991) Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 325:1487\u20131498","journal-title":"N Engl J Med"},{"issue":"8","key":"527_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4065\/82.8.976","volume":"82","author":"JH Ryu","year":"2007","unstructured":"Ryu JH, Daniels CE, Hartman TE, Yi ES (2007) Diagnosis of interstitial lung diseases. Mayo Clin Proc 82(8):976\u2013986","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"527_CR25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"527_CR26","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"527_CR27","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease (ISGBD)","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (ISGBD) (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"527_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","volume":"55","author":"LP McAdam","year":"1976","unstructured":"McAdam LP, O\u2019Hanlan MA, Bluestone R, Pearson CM (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55:193\u2013215","journal-title":"Medicine"},{"key":"527_CR29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1148\/radiology.215.3.r00jn31884","volume":"215","author":"KA Kurdziel","year":"2000","unstructured":"Kurdziel KA (2000) The panda sign. Radiology 215:884\u2013885","journal-title":"Radiology"},{"issue":"3","key":"527_CR30","first-page":"217","volume":"50","author":"M Chianelli","year":"2006","unstructured":"Chianelli M, D\u2019Alessandria C, Conti F, Valesini G, Annovazzi A, Signore A (2006) New radiopharmaceuticals for imaging rheumatoid arthritis. Q J Nucl Med Mol Imaging 50(3):217\u2013225","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"5","key":"527_CR31","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1021\/cr900351r","volume":"110","author":"A Signore","year":"2010","unstructured":"Signore A, Mather SJ, Piaggio G, Priori R, Malviya G, Dierckx RA (2010) Molecular imaging of inflammation\/infection: nuclear medicine and optical imaging agents and methods. Chem Rev 110(5):3112\u20133145","journal-title":"Chem Rev"},{"issue":"12","key":"527_CR32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/MNM.0b013e3283134d6e","volume":"29","author":"T Gmeiner Stopar","year":"2008","unstructured":"Gmeiner Stopar T, Fettich J, Zver S, Mlinaric-Rascan I, Hojker S, Socan A, Peitl PK, Mather S (2008) 99mTc-labelled rituximab, a new non-Hodgkin\u2019s lymphoma imaging agent: first clinical experience. Nucl Med Commun 29(12):1059\u20131065","journal-title":"Nucl Med Commun"},{"issue":"2","key":"527_CR33","first-page":"13","volume":"52","author":"G Malviya","year":"2008","unstructured":"Malviya G, D\u2019Alessandria C, Lanzolla T, Lenza A, Conti F, Valesini G, Scopinaro F, Dierckx RA, Signore A (2008) 99\u00a0m-Technetium labelled anti-TNF\u03b1 antibodies for the therapy decision making and follow-up of patients with rheumatoid arthritis. Q J Nucl Med Mol Imaging; 52 Suppl 1(2):13","journal-title":"Q J Nucl Med Mol Imaging"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-011-0527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-011-0527-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-011-0527-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-011-0527-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T10:17:36Z","timestamp":1686478656000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-011-0527-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,30]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1007\/s11307-011-0527-x","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,30]]}}}